HIV-1-Specific Immune Response

Advances in Pharmacology

Volumn 56, Issue , 2008, Pages 75-92

  Harari, Alexandre ^a   Pantaleo, Giuseppe ^a  

^a Laboratory of AIDS Immunopathogenesis   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY PRODUCTION; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANTIBODY FORMATION; HIV-1; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; T-LYMPHOCYTES;

EID: 37249077564     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(07)56003-5     Document Type: Review

References (84)

1. Addo M.M., Yu X.G., Rathod A., Cohen D., Eldridge R.L., Strick D., Johnston M.N., Corcoran C., Wurcel A.G., Fitzpatrick C.A., Feeney M.E., Rodriguez W.R., et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77 (2003) 2081-2092
2. Alcami A., and Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today 21 (2000) 447-455
3. Altfeld M., Rosenberg E.S., Shankarappa R., Mukherjee J.S., Hecht F.M., Eldridge R.L., Addo M.M., Poon S.H., Phillips M.N., Robbins G.K., Sax P.E., Boswell S., et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193 (2001) 169-180
4. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A., Havlir D.V., Richman D.D., et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192 (2000) 63-75
5. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., Ogg G.S., King A., Lechner F., Spina C.A., Little S., Havlir D.V., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8 (2002) 379-385
6. Arvin A.M. Immune responses to varicella-zoster virus. Infect. Dis. Clin. North Am. 10 (1996) 529-570
7. Autran B., Legac E., Blanc C., and Debre P. A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J. Immunol. 154 (1995) 1408-1417
8. Bachmann M.F., and Kopf M. The role of B cells in acute and chronic infections. Curr. Opin. Immunol. 11 (1999) 332-339
9. Bachmann M.F., and Zinkernagel R.M. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15 (1997) 235-270
10. Bertoletti A., and Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 38 (2003) 4-13
11. Betts M.R., Krowka J.F., Kepler T.B., Davidian M., Christopherson C., Kwok S., Louie L., Eron J., Sheppard H., and Frelinger J.A. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res. Hum. Retroviruses 15 (1999) 1219-1228
12. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., and Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281 (2003) 65-78
13. Betts M.R., Price D.A., Brenchley J.M., Lore K., Guenaga F.J., Smed-Sorensen A., Ambrozak D.R., Migueles S.A., Connors M., Roederer M., Douek D.C., Koup R.A., et al. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172 (2004) 6407-6417
14. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., Lederman M.M., Benito J.M., Goepfert P.A., Connors M., Roederer M., Koup R.A., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 (2006) 4781-4789
15. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., Casazza J.P., Kuruppu J., Migueles S.A., Connors M., Roederer M., Douek D.C., et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101 (2003) 2711-2720
16. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., and Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
17. Buchacher A., Predl R., Strutzenberger K., Steinfellner W., Trkola A., Purtscher M., Gruber G., Tauer C., Steindl F., Jungbauer A., et al. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retroviruses 10 (1994) 359-369
18. Burton D.R., Pyati J., Koduri R., Sharp S.J., Thornton G.B., Parren P.W., Sawyer L.S., Hendry R.M., Dunlop N., Nara P.L., et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266 (1994) 1024-1027
19. Burton D.R., Desrosiers R.C., Doms R.W., Koff W.C., Kwong P.D., Moore J.P., Nabel G.J., Sodroski J., Wilson I.A., and Wyatt R.T. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5 (2004) 233-236
20. Callan M.F. The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol. 16 (2003) 3-16
21. Cao J., McNevin J., Holte S., Fink L., Corey L., and McElrath M.J. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J. Virol. 77 (2003) 6867-6878
22. Carotenuto P., Looij D., Keldermans L., de Wolf F., and Goudsmit J. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection. AIDS 12 (1998) 1591-1600
23. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G.P., Fleury S., Lipp M., Forster R., Rowland-Jones S., et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 (2001) 106-111
24. Doherty P.C., and Christensen J.P. Accessing complexity: The dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 18 (2000) 561-592
25. Doherty P.C., Christensen J.P., Belz G.T., Stevenson P.G., and Sangster M.Y. Dissecting the host response to a gamma-herpesvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (2001) 581-593
26. Ellefsen K., Harari A., Champagne P., Bart P.A., Sekaly R.P., and Pantaleo G. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Eur. J. Immunol. 32 (2002) 3756-3764
27. Gandhi R.T., and Walker B.D. Immunologic control of HIV-1. Annu. Rev. Med. 53 (2002) 149-172
28. Gillespie G.M., Wills M.R., Appay V., O'Callaghan C., Murphy M., Smith N., Sissons P., Rowland-Jones S., Bell J.I., and Moss P.A. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J. Virol. 74 (2000) 8140-8150
29. Griffin D.E. Immune responses during measles virus infection. Curr. Top. Microbiol. Immunol. 191 (1995) 117-134
30. Hamann D., Baars P.A., Rep M.H., Hooibrink B., Kerkhof-Garde S.R., Klein M.R., and van Lier R.A. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186 (1997) 1407-1418
31. Harari A., Vallelian F., and Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34 (2004) 3525-3533
32. Harari A., Zimmerli S.C., and Pantaleo G. Cytomegalovirus (CMV)-specific cellular immune responses. Hum. Immunol. 65 (2004) 500-506
33. Harari A., Petitpierre S., Vallelian F., and Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: Changes after antiretroviral therapy. Blood 103 (2004) 966-972
34. Harari A., Vallelian F., Meylan P.R., and Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174 (2005) 1037-1045
35. Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., and Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 211 (2006) 236-254
36. Iyasere C., Tilton J.C., Johnson A.J., Younes S., Yassine-Diab B., Sekaly R.P., Kwok W.W., Migueles S.A., Laborico A.C., Shupert W.L., Hallahan C.W., Davey Jr. R.T., et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77 (2003) 10900-10909
37. Kaech S.M., Wherry E.J., and Ahmed R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat. Rev. Immunol. 2 (2002) 251-262
38. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., and Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4 (2003) 1191-1198
39. Kaufmann D.E., Bailey P.M., Sidney J., Wagner B., Norris P.J., Johnston M.N., Cosimi L.A., Addo M.M., Lichterfeld M., Altfeld M., Frahm N., Brander C., et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78 (2004) 4463-4477
40. Kaul R., Rutherford J., Rowland-Jones S.L., Kimani J., Onyango J.I., Fowke K., MacDonald K., Bwayo J.J., McMichael A.J., and Plummer F.A. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: A prospective analysis. AIDS 18 (2004) 2087-2089
41. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13 (2007) 46-53
42. Klenerman P., and Hill A. T cells and viral persistence: Lessons from diverse infections. Nat. Immunol. 6 (2005) 873-879
43. Letvin N.L. Progress toward an HIV vaccine. Annu. Rev. Med. 56 (2005) 213-223
44. Letvin N.L. Progress and obstacles in the development of an AIDS vaccine. Nat. Rev. Immunol. 6 (2006) 930-939
45. Lichterfeld M., Kaufmann D.E., Yu X.G., Mui S.K., Addo M.M., Johnston M.N., Cohen D., Robbins G.K., Pae E., Alter G., Wurcel A., Stone D., et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med. 200 (2004) 701-712
46. Lichterfeld M., Yu X.G., Mui S.K., Williams K.L., Trocha A., Brockman M.A., Allgaier R.L., Waring M.T., Koibuchi T., Johnston M.N., Cohen D., Allen T.M., et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J. Virol. 81 (2007) 4199-4214
47. Makedonas G., Bruneau J., Alary M., Tsoukas C.M., Lowndes C.M., Lamothe F., and Bernard N.F. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS 19 (2005) 251-259
48. Mallard E., Vernel-Pauillac F., Velu T., Lehmann F., Abastado J.P., Salcedo M., and Bercovici N. IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity. J. Immunol. 172 (2004) 3963-3970
49. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
50. McMichael A.J. HIV vaccines. Annu. Rev. Immunol. 24 (2006) 227-255
51. McMichael A.J., and Phillips R.E. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15 (1997) 271-296
52. McMichael A.J., Callan M., Appay V., Hanke T., Ogg G., and Rowland-Jones S. The dynamics of the cellular immune response to HIV infection: Implications for vaccination. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355 (2000) 1007-1011
53. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C.W., Van Baarle D., Kostense S., Miedema F., McLaughlin M., Ehler L., Metcalf J., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3 (2002) 1061-1068
54. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., and Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67 (1993) 6642-6647
55. Palmer B.E., Boritz E., and Wilson C.C. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. J. Immunol. 172 (2004) 3337-3347
56. Pantaleo G., and Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6 (2006) 417-423
57. Pantaleo G., and Koup R.A. Correlates of immune protection in HIV-1 infection: What we know, what we don't know, what we should know. Nat. Med. 10 (2004) 806-810
58. Pantaleo G., Demarest J.F., Soudeyns H., Graziosi C., Denis F., Adelsberger J.W., Borrow P., Saag M.S., Shaw G.M., Sekaly R.P., and Fauci A.S. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370 (1994) 463-467
59. Pantophlet R., and Burton D.R. GP120: Target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 24 (2006) 739-769
60. Pitcher C.J., Quittner C., Peterson D.M., Connors M., Koup R.A., Maino V.C., and Picker L.J. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5 (1999) 518-525
61. Purtscher M., Trkola A., Gruber G., Buchacher A., Predl R., Steindl F., Tauer C., Berger R., Barrett N., Jungbauer A., et al. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 10 (1994) 1651-1658
62. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., and Walker B.D. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278 (1997) 1447-1450
63. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., Robbins G.K., D'Aquila R.T., Goulder P.J., and Walker B.D. Immune control of HIV-1 after early treatment of acute infection. Nature 407 (2000) 523-526
64. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
65. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu. Rev. Immunol. 22 (2004) 745-763
66. Schmitz J.E., Johnson R.P., McClure H.M., Manson K.H., Wyand M.S., Kuroda M.J., Lifton M.A., Khunkhun R.S., McEvers K.J., Gillis J., Piatak M., Lifson J.D., et al. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques. J. Virol. 79 (2005) 8131-8141
67. Seder R.A., and Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4 (2003) 835-842
68. Sprent J., and Surh C.D. T cell memory. Annu. Rev. Immunol. 20 (2002) 551-579
69. Stiegler G., Kunert R., Purtscher M., Wolbank S., Voglauer R., Steindl F., and Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17 (2001) 1757-1765
70. Suni M.A., Maino V.C., and Maecker H.T. Ex vivo analysis of T-cell function. Curr. Opin. Immunol. 17 (2005) 434-440
71. Tilton J.C., Luskin M.R., Johnson A.J., Manion M., Hallahan C.W., Metcalf J.A., McLaughlin M., Davey Jr. R.T., and Connors M. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J. Virol. 81 (2007) 2713-2725
72. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J.P., and Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70 (1996) 1100-1108
73. Trkola A., Kuster H., Rusert P., Joos B., Fischer M., Leemann C., Manrique A., Huber M., Rehr M., Oxenius A., Weber R., Stiegler G., et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat. Med. 11 (2005) 615-622
74. van Baarle D., Kostense S., van Oers M.H., Hamann D., and Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol. 23 (2002) 586-591
75. van Lier R.A., ten Berge I.J., and Gamadia L.E. Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 3 (2003) 931-939
76. Walker B.D., and Goulder P.J. AIDS. Escape from the immune system. Nature 407 (2000) 313-314
77. Weekes M.P., Carmichael A.J., Wills M.R., Mynard K., and Sissons J.G. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J. Immunol. 162 (1999) 7569-7577
78. Weekes M.P., Wills M.R., Mynard K., Hicks R., Sissons J.G., and Carmichael A.J. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population. Immunology 98 (1999) 443-449
79. Younes S.A., Yassine-Diab B., Dumont A.R., Boulassel M.R., Grossman Z., Routy J.P., and Sekaly R.P. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 198 (2003) 1909-1922
80. Zimmerli S.C., Harari A., Cellerai C., Vallelian F., Bart P.A., and Pantaleo G. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. USA 102 (2005) 7239-7244
81. Zinkernagel R.M., Bachmann M.F., Kundig T.M., Oehen S., Pirchet H., and Hengartner H. On immunological memory. Annu. Rev. Immunol. 14 (1996) 333-367
82. Zinkernagel R.M., LaMarre A., Ciurea A., Hunziker L., Ochsenbein A.F., McCoy K.D., Fehr T., Bachmann M.F., Kalinke U., and Hengartner H. Neutralizing antiviral antibody responses. Adv. Immunol. 79 (2001) 1-53
83. Zwick M.B., Bonnycastle L.L., Menendez A., Irving M.B., Barbas III C.F., Parren P.W., Burton D.R., and Scott J.K. Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12. J. Virol. 75 (2001) 6692-6699
84. Zwick M.B., Jensen R., Church S., Wang M., Stiegler G., Kunert R., Katinger H., and Burton D.R. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J. Virol. 79 (2005) 1252-1261